Maalox name confusion brings a growing consumer concern to light

As most of you probably read or heard about in the news, this past Wednesday the FDA warned consumers about a potential mix-up in buying Maalox products and treating different medical conditions.  This may seem a little hard to believe, but it happens more and more leaving consumers compromised and subject to serious side effects by brands trying to capture more of the Over The Counter market. As a pharmacist, I routinely see people who come in to the pharmacy asking for a particular brand name product like Excedrin, Alka-Seltzer, or Robitussin.   When they get to the aisle to find these medications, more than 10 or 12 different products all using the same brand name may be waiting for them.  At this point, they make one of two choices:  to either come ask the pharmacist for more information, or … Continue reading →